Ireland
--:--IST
Latest
Clinical Trials in France / NCT06185491
Active, not recruiting Not applicable

Assessment of HGI (Hemoglobin Glycation Index) Variability Over Time in Patients Living With Diabetes Using Continuous Glucose Monitoring ( GAP OUEST )

NCT06185491 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2024-06-24
Last updated
2026-05-26

Condition(s) studied

Diabetes Mellitus

Investigational drug(s) / intervention(s)

HGI

HGI: Data collection from glucose monitoring systems and dosage of glycated hemoglobin and glycated albumin measured 3 times at 6-month intervals (+/- 3 months)

Study summary

The goal of this clinical trial is to learn about the variability of HGI (Hemoglobin Glycation Index) over time in patients living with diabetes using a continuous glucose monitoring.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Major (adult subject over 18), with no upper age limit * Enrolled in a social security scheme or beneficiary of such a scheme * Agreement to participate (informed, written consent) * Established diabetes (regardless the type of diabetes), known for at least 6 months at inclusion * Regular user of a glucose monitoring system for at least 3 months. Non inclusion Criteria: * Known hemoglobinopathy * Inadequate use of the flash glucose monitoring system with a capture rate of less than 70% of interstitial glucose measurements, during the 3 months preceding the inclusion visit. * Stage 5 renal insufficiency (CKD-EPI less than 15 mL/min/1.73 m2) * Pregnant or breast-feeding * Major under guardianship, curatorship or safeguard of justice * Any situation assessed by the investigator as potentially prejudicial to the participant's health as a result of participation in the study Exclusion criteria: * Treatment with corticosteroids in the 3 months preceding the visit * Unusual acute situation (infection, very unusual physical activity, etc.) deemed significant by the investigator * Pregnancy started

Primary outcome measure(s)

Trial sites (9)

FacilityCityRegionStatus
CHU d'Angers Angers France
CHU de Brest Brest France
CHU de Caen Caen France
CH du Mans Le Mans France
CHU de Nantes Nantes France
CHU de Poitiers Poitiers France
Hôpital NOVO Pontoise France
CHU de Rennes Rennes France
CHU de Toulouse Toulouse France

More Nantes University Hospital trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06185491 on ClinicalTrials.gov ↗ ← All trials in France